Edition:
United Kingdom

Karyopharm Therapeutics Inc (KPTI.OQ)

KPTI.OQ on NASDAQ Stock Exchange Global Select Market

14.05USD
23 Apr 2018
Change (% chg)

$-0.54 (-3.70%)
Prev Close
$14.59
Open
$14.72
Day's High
$14.75
Day's Low
$13.84
Volume
212,641
Avg. Vol
121,630
52-wk High
$17.95
52-wk Low
$7.54

Select another date:

Tue, Apr 10 2018

BRIEF-Karyopharm's Selinexor Receives Fast Track Designation From FDA

* KARYOPHARM'S SELINEXOR RECEIVES FAST TRACK DESIGNATION FROM FDA FOR THE TREATMENT OF PATIENTS WITH PENTA-REFRACTORY MULTIPLE MYELOMA

BRIEF-Karyopharm Therapeutics Reports Q4 Loss Per Share Of $0.80

* KARYOPHARM REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS

BRIEF-Karyopharm Announces Agreement For Biogen To Acquire KPT-350

* KARYOPHARM ANNOUNCES AGREEMENT FOR BIOGEN TO ACQUIRE KPT-350 FOR THE TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE CONDITIONS

BRIEF-Karyopharm Therapeutics Says Co May Issue & Sell Shares Of Stock

* KARYOPHARM THERAPEUTICS - CO MAY ISSUE & SELL SHARES OF STOCK, $0.0001 PAR VALUE PER SHARE, HAVING ADDITIONAL OFFERING PRICE OF UP TO $75 MILLION

BRIEF-Point72 Asset Management L.P. reports 7.3 pct passive stake in Karyopharm Therapeutics Inc as of Nov. 3 - SEC filing‍​

* Point72 Asset Management L.P. reports 7.3 percent passive stake in Karyopharm Therapeutics Inc as of November 3, 2017 - SEC filing‍​ Source text: (http://bit.ly/2h9XeaC) Further company coverage:

BRIEF-Karyopharm Q3 loss per share $0.65

* Karyopharm reports third quarter 2017 financial results and highlights recent progress

Select another date: